国产99久久精品_欧美日本韩国一区二区_激情小说综合网_欧美一级二级视频_午夜av电影_日本久久精品视频

歐蒙 EUROIMMUN    
歐蒙醫學實驗診斷股份公司創建于1987年9月，現總部位于德國呂貝克市，在Gro? Gr?nau，Rennersdorf和Pegnitz設有分部。歐蒙公司在加拿大（米西索加）、中國（北京，杭州）、英國（新港）、意大利（帕多瓦）、黎巴嫩（貝魯特）、波蘭（弗羅茨瓦夫）、瑞士（洛桑）、新加坡、南非（開普敦）、土耳其（伊斯坦布爾）、美國（新澤西州）設有分公司，現有員工近2000人。公司已取得ISO認證（EN ISO 9001:2000, EN ISO 13485:2003, ISO 13485/CMDCAS）。

歐蒙公司是醫學實驗診斷試劑的生產企業，在自身免疫性疾病、感染性疾病和變態反應性疾病的血清抗體檢測領域位于世界前沿。歐蒙公司產品采用的實驗方法主要有間接免疫熒光法、微孔板ELISA法、各種印跡技術（免疫印跡法、歐蒙斑點法、歐蒙印跡法和EUROLINE-WB）和分子生物學技術。基于已在全球范圍獲得專利的完美生產工藝和微量檢測技術，歐蒙公司正成為醫學實驗診斷領域的世界領先制造商。

生物薄片（BIOCHIPs ）是歐蒙公司眾多創新技術之一：將細胞或組織切片包被在極薄的蓋玻片上，再用自動化機械將其切割成毫米大小的片段，隨后用全自動的儀器將它們固定在載片上。這種生物薄片技術可使實驗分析高度微量化和標準化。生物薄片馬賽克（BIOCHIP Mosaics?）可將30種或更多的不同組織、細胞基質或性質明確的抗原（EUROPLUS?）進行組合，僅需要簡單的實驗溫育，即可獲得詳盡的自身抗體譜信息。

歐蒙酶聯免疫分析（ELISA）試劑采用經先進生物技術純化的抗原作為檢測基質，很多抗原是由歐蒙分子生物學實驗室合成。歐蒙ELISA具有穩定性好、操作簡單、溫育時間短和適于自動化等優點。試劑盒中大多數成分可直接使用，并且不同批次之間可互換。歐蒙公司現可提供世界上最多種類的用于自身免疫性疾病和感染性疾病診斷的酶聯免疫檢測試劑。

歐蒙斑點法(EUROASSAY) 和歐蒙印跡法(EUROLINE)是歐蒙公司的革新技術。其遵循ELISA法的實驗原理，并使用滴定平板技術和生物薄片技術：將純化的抗原平行印在膜條上的指定位置。溫育后，不需用其它設備就可目測結果。歐蒙斑點法和歐蒙印跡法特別適合于間接免疫熒光法中顯微鏡下不能確定的抗體分型，也適合于無精密實驗設備的實驗室使用。歐蒙公司還提供多種免疫印跡法試劑盒和相應試劑，用于確認免疫熒光法和ELISA的陽性結果以及自身免疫性疾病、感染性疾病和變態反應性疾病診斷中的疑難樣本；并且，歐蒙已研發出新型電泳系統用于精確分離具有診斷意義的相關蛋白條帶，同時提供批特異的參照膜條用于檢測結果的分析。結果分析軟件EURO-LineScan可使以膜為載體的檢測系統實現結果的計算機自動判讀，簡化了大量標本的結果分析。

歐蒙公司卓越的技術優勢不僅體現在生產和銷售醫學實驗診斷產品上，也表現于公司參考實驗室應用這些產品進行高級鑒別診斷上。此參考實驗室建立了德國乃至世界范圍內統一的自身免疫性疾病實驗室檢測標準。該實驗室的檢測項目還覆蓋了感染性疾病和變態反應性疾病的血清學診斷，每天為來自德國和其它國家的上百份血清樣品進行免費檢測。這樣不僅有助于歐蒙客戶獲得準確的實驗結果，還保證了客戶實驗室的高水準。客戶還可從公司的資深專家那里獲得豐富的技術信息，并與他們就血清學領域中的問題進行深入討論。歐蒙公司新成立了質量保證研究所，負責組織公正的質量評估并就質量管理中的問題提出建議。另外，歐蒙公司還建立了實驗主要從事基礎研究的免疫學研究所。

截止到2010年10月，歐蒙（德國）員工中有150名大學畢業生，他們中有生物學家、生化學家、化學家、工程師和臨床醫生（其中48人獲得博士學位）。歐蒙還有103名與公司業務相應的醫學技術人員和81名生物化學/化學實驗室技術員。現在有55個年輕人在公司接受培訓，他們將來承擔生物實驗室技術員、職員、IT專家、電子系統技師、儀器和系統電子技師和工程機械師等工作。

歐蒙公司致力于引導客戶使用先進的技術，支持客戶使用對診斷有幫助的產品，努力淡化商業行為。歐蒙產品的成功推廣基于充滿朝氣并具有競爭力的銷售團隊、優質的信息資料、詳細易讀的產品說明書和在專業雜志上刊登富有科學性、普及性的廣告宣傳。公司使用最先進的編輯制作方法和數碼成像系統自己制作各種宣傳資料，重要的出版物和產品彩頁已翻譯成多種語言。歐蒙公司在互聯網上的主頁：www.euroimmun.com，歡迎全球朋友訪問。

目前世界上已有3000多家實驗室在使用歐蒙公司的產品，其中400多家在德國。歐蒙公司正日益發展壯大。盡管德國的診斷試劑市場停滯不前并且競爭激烈，但歐蒙公司仍保持強勁的發展勢頭。隨著越來越多的產品銷往世界各地，歐蒙在德國市場獨樹一幟。歐蒙的產品以其優秀品質占據著世界領先地位。

EUROIMMUN produces a wide range of reagents for medical laboratory diagnostics. The main focus is on test systems for antibodies in patient serum. These allow highly sensitive and specific diagnosis of autoimmune diseases, infectious diseases and allergies.

Test methods are predominantly indirect immunofluorescence, microplate ELISA, various blot techniques (Westernblot, EUROASSAY, EUROLINE, EUROLINE-WB), RIA and all molecular biology techniques. EUROIMMUN also offers a comprehensive range of automation solutions. With innovative and patented production methods and microanalysis techniques, EUROIMMUN is one of the world's leading manufacturers of medical laboratory diagnostics.

EUROIMMUN was founded in September 1987 and today has its headquarters in Luebeck, Germany. German branches are situated in Gross Groenau near Luebeck (Schleswig Holstein), Dassow (Mecklenburg-Western Pomerania), Rennersdorf (Upper Lusatia, Saxony) and in Pegnitz (Upper Franconia, Bavaria). Further EUROIMMUN AG subsidiaries can be found in Canada (Mississauga), China (Beijing, Hangzhou), Great Britain (Wimbledon), Italy (Padua), Poland (Wroc--?aw), Switzerland (Lucerne), Singapore, South Africa (Cape-town), Brazil (Porto Alegre), Turkey (Istanbul) and the USA (New Jersey). At present EUROIMMUN has 944employees in Germany, 1311 worldwide. The company is ISO-certified (EN ISO 9001:2008, EN ISO 13485:2003/CMDCAS).

EUROIMMUN produces reagents for medical laboratory diagnostics. In the foreground are test systems for the determination of various antibodies in patient serum in the diagnosis of autoimmune diseases, infectious diseases and allergies. The test methods employed are predominantly indirect immunofluorescence, microplate ELISA, various blot techniques (Westernblot, EUROASSAY, EUROLINE, EUROLINE-WB) and all molecular biology techniques. The company is based on worldwide-patented state-of-the-art production methods and microanalysis techniques and is one of the world’s leading manu-facturers of medical laboratory diagnostics.

The BIOCHIPs are one of EUROIMMUN’s many inventions: paper-thin sheets of glass are coated with cells or tissue sections and then cut automatically into millimetre-sized fragments which are subsequently glued onto slides using a fully automated device. This BIOCHIP technology allows extreme miniaturization and standardization of immun-bio-chemical analyses. With BIOCHIP Mosaics?made from 30 or more different organ sections, cell substrates or defined antigens (EUROPLUS?) only mini-mum incubation efforts are necessary to obtain a detailed antibody profile.

In EUROIMMUN enzyme immunoassays (ELISAs) defined antigens, purified using state-of-the-art biotechnological processes, are employed as the antigen substrate. Some of these antigens are synthesized in the company’s molecular biology laboratories. EUROIMMUN ELISA are characterized by their excellent stability, simple handling and short incubation times, and they are ideal for automated use. All reagents are delivered ready-to-use and are exchangeable between different lots. EUROIMMUN offers the largest and most differentiated arsenal of enzyme immunoassays worldwide for the diagnosis of autoimmune and infectious diseases.

The innovative procedures EUROASSAY and EUROLINE developed by EUROIMMUN follow the same test principle as the ELISA methods, with the use of the BIOCHIP technology. At EUROIMMUN purified antigens are printed in parallel lines at defined positions on membrane strips. Following incubation, users can evaluate results visually without additional equipment. These reagents allow in particular the differentiation of antibodies that are not clearly defined microscopically by indirect immunofluorescence. EUROASSAY and EUROLINE are also em-ployed in laboratories where no sophisticated laboratory instruments are available. EUROIMMUN produces an extensive range of Westernblot strip test systems and corres-ponding reagents for confirmation of positive fluorescence and ELISA results as well as clarification of difficult-to-interpret results in autoimmune diagnostics, infectious serology and allergology. Refined electrophoretical processes have been developed to allow the precise separation of diagnostically relevant proteins from one another. Lot-specific evalu-ation templates are produced for the evaluation of band patterns. The program ”EURO-LineScan“ enables fully automated evaluation of membrane-based test systems and simplifies the archiving of results with large sample series.

One of the company’s main strengths is its technical expertise. This encompasses not just the manufacture and sale of medical laboratory diagnostics, but also the diagnostic application of the products in a reference laboratory which provides highly differential diagnostics. This reference laboratory has set standards in Germany, and worldwide is unequalled in the whole field of autoimmune diagnostics. The diagnostic spectrum of the laboratory also covers the areas of infectious serology and serological allergy diagnostics. The reference laboratory receives hundreds of serum samples daily from all over Germany as well as from many other countries. It helps EUROIMMUN customers to secure their results: a large proportion of serum samples sent to EUROIMMUN for evaluation are analysed free of charge in order to maintain high standards in the laboratories of EUROIMMUN customers. Customers can obtain further technical information from experienced scientists in the company, with whom they can also discuss serological problem cases. The “Institute for Quality Assurance”, an institution newly founded by EUROIMMUN, organises unbiased quality assessments and provides advice in the area of quality management. Moreover EUROIMMUN has established the “Institute for experimental Immunology”, which is engaged in basic research.

In October 2012 the EUROIMMUN workforce included 170 university and college graduates, among these biologists, biochemists, chemists, engineers and medical doctors (48 of them holding a doctor’s degree). Medical technicians are particularly strongly represented with 111 people, corresponding to EUROIMMUN’s activities, as well as biology/chemistry laboratory technicians (81). At present the company is training 51 young people as biology laboratory assistants, industrial clerks, office communication clerks, IT specialists, IT clerks, electronic system technicians, electronic technicians for devices and systems, industrial mechanics, cooks, computer scientists and business economists (dual system).

At EUROIMMUN great value is placed on advising customers and prospective customers in a factual, technical and commercially restrained manner and fully supporting them in the use of our diagnostically demanding products. EUROIMMUN products are backed by an energetic and competent sales force, qualified information material, didactic test instructions and scientifically based, but nevertheless understandable advertisements in technical journals. Advertising material is produced in-house using the latest desktop publishing methods, right up until the fully digitalised ready-for-exposure documents. The most important publications and posters are translated into many languages.

Over 3,000 laboratories worldwide use EUROIMMUN diagnostics: 400 of these are in Ger-many. The company’s development is shaped by continuous growth. Although the diagnostic market in Germany stagnated and has become particularly strongly competitive, EURO-IMMUN has been able to continue its strong expansion. The company is achieving an ever increasing independence from the German market, since more and more products are sold abroad. With their quality and standardization, EUROIMMUN products are capturing the leading position in the world.